Search

everythinglearnresearchcommunity

for

Search:↓

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

Shift work disrupts the body's natural clock, leading to health problems.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Suppressing certain hormones might help prevent prostate cancer.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

The research suggests that p63 and TGF-β1 may help determine tumor type and malignancy in hair follicle and sebaceous tumors.

Germany recognizes skin cancer from UV exposure as an occupational disease, emphasizing prevention and care for affected workers.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.